These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1389908)

  • 1. Monoclonal antibody therapy.
    Schwartz MA; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1992; 13():156-74. PubMed ID: 1389908
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibody therapy of cancer.
    Jurcic JG; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1994; 15():152-75. PubMed ID: 7779584
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibody therapy of cancer.
    Jurcic JG; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1997; 17():195-216. PubMed ID: 9551215
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative evaluation of capsular polysaccharide-specific IgM and IgG antibodies and F(ab')2 and Fab fragments as delivery vehicles for radioimmunotherapy of fungal infection.
    Dadachova E; Bryan RA; Huang X; Ortiz G; Moadel T; Casadevall A
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5629s-5635s. PubMed ID: 17875799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia.
    Robertson MJ; Roy DC; Stone RM; Ritz J
    Prog Clin Biol Res; 1994; 389():47-63. PubMed ID: 7700916
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice.
    Engert A; Martin G; Pfreundschuh M; Amlot P; Hsu SM; Diehl V; Thorpe P
    Cancer Res; 1990 May; 50(10):2929-35. PubMed ID: 1692251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotoxin therapy of cancer.
    Frankel AE
    Oncology (Williston Park); 1993 May; 7(5):69-78; discussion 79-80, 83-6. PubMed ID: 8512787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody therapy for indolent lymphomas.
    Grossbard ML; Nadler LM
    Semin Oncol; 1993 Oct; 20(5 Suppl 5):118-35. PubMed ID: 8211202
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoclonal antibody-mediated targeting of alkylating agents for the treatment of cancer.
    Smyth MJ; Pietersz GA; Farquhar I; McKenzie C
    Targeted Diagn Ther; 1988; 1():123-56. PubMed ID: 2979055
    [No Abstract]   [Full Text] [Related]  

  • 10. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in monoclonal antibody therapy of cancer.
    LoBuglio AF; Saleh MN
    Am J Med Sci; 1992 Sep; 304(3):214-24. PubMed ID: 1476160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of monoclonal antibodies in the diagnosis and therapy of cancer.
    Vaickus L; Foon KA
    Cancer Invest; 1991; 9(2):195-209. PubMed ID: 1863875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies, cytokines and fusion proteins in the treatment of malignant disease.
    Hank JA; Albertini MR; Sondel PM
    Cancer Chemother Biol Response Modif; 1999; 18():210-22. PubMed ID: 10800484
    [No Abstract]   [Full Text] [Related]  

  • 14. Improving the efficacy of antibody-based cancer therapies.
    Carter P
    Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
    Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies and immunoconjugates for cancer treatment.
    Baldwin RW; Byers VS
    Cancer Chemother Biol Response Modif; 1987; 9():409-31. PubMed ID: 3079412
    [No Abstract]   [Full Text] [Related]  

  • 17. [Radioimmunotherapy with 131 I-labeled humanized anti-HBsAg Fab and anti-nucleus antigen monoclonal antibody chTNT in nude mice bearing human hepatocellular carcinoma].
    DU YF; Luo RC; Li GP; Li AM; Ding XM; Yan X; Huang K
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):460-2. PubMed ID: 18359714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the therapeutic use of new monoclonal antibodies.
    Colnaghi MI; Ménard S; Canevari S
    Curr Opin Oncol; 1993 Nov; 5(6):1035-42. PubMed ID: 8305536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic use of immunotoxins.
    Cobb PW; LeMaistre CF
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):6-13. PubMed ID: 1509295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruiting dendritic cells to improve antibody therapy of cancer.
    Dhodapkar KM; Dhodapkar MV
    Proc Natl Acad Sci U S A; 2005 May; 102(18):6243-4. PubMed ID: 15851655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.